Related references
Note: Only part of the references are listed.The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma
Hisham F. Bahmad et al.
Oncotarget (2018)
Antiproliferative and apoptotic effects of xanthohumol in cholangiocarcinoma
Daniel Walden et al.
ONCOTARGET (2017)
Structural basis of N-Myc binding by Aurora-A and its destabilization by kinase inhibitors
Mark W. Richards et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study
L. L. Wang et al.
BRITISH JOURNAL OF CANCER (2015)
Survivors of Childhood Cancer in the United States: Prevalence and Burden of Morbidity
Siobhan M. Phillips et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Role for the PI3K/Akt/Nrf2 signaling pathway in the protective effects of carnosic acid against methylglyoxal-induced neurotoxicity in SH-SY5Y neuroblastoma cells
Marcos Roberto de Oliveira et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
PI3King the Lock: Targeting the PI3K/Akt/mTOR Pathway as a Novel Therapeutic Strategy in Neuroblastoma
David King et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2015)
Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells
Selvi Kunnimalaiyaan et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Xanthohumol Inhibits Notch Signaling and Induces Apoptosis in Hepatocellular Carcinoma
Selvi Kunnimalaiyaan et al.
PLOS ONE (2015)
Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation
G. Cheng et al.
BRITISH JOURNAL OF CANCER (2014)
Up-Regulation of P21 Inhibits TRAIL-Mediated Extrinsic Apoptosis, Contributing Resistance to SAHA in Acute Myeloid Leukemia Cells
Xing Wu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Human pharmacokinetics of xanthohumol, an antihyperglycemic flavonoid from hops
LeeCole Legette et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2014)
Pharmacokinetics of prenylated hop phenols in women following oral administration of a standardized extract of hops
Richard B. van Breemen et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2014)
Mechanisms of neuroblastoma regression
Garrett M. Brodeur et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Age-Dependent Prognostic Effect by Mitosis-Karyorrhexis Index in Neuroblastoma: A Report from the Children's Oncology Group
Risa Teshiba et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2014)
The antitumor lignan Nortrachelogenin sensitizes prostate cancer cells to TRAIL-induced cell death by inhibition of the Akt pathway and growth factor signaling
Emilia Peuhu et al.
BIOCHEMICAL PHARMACOLOGY (2013)
The radio-sensitizing effect of xanthohumol is mediated by STAT3 and EGFR suppression in doxorubicin-resistant MCF-7 human breast cancer cells
Youra Kang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Neuroblastoma of Undifferentiated Subtype, Prognostic Significance of Prominent Nucleolar Formation, and MYC/MYCN Protein Expression
Larry L. Wang et al.
CANCER (2013)
Xanthohumol lowers body weight and fasting plasma glucose in obese male Zucker fa/fa rats
LeeCole L. Legette et al.
PHYTOCHEMISTRY (2013)
Peripheral neuroblastic tumors with genotype-phenotype discordance: A report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee
Rie Suganuma et al.
PEDIATRIC BLOOD & CANCER (2013)
The mTOR Signaling Pathway in Pediatric Neuroblastoma
Hong Mei et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2013)
Neuroblastoma and MYCN
Miller Huang et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Xanthohumol Impairs Human Prostate Cancer Cell Growth and Invasion and Diminishes the Incidence and Progression of Advanced Tumors in TRAMP Mice
Roberta Vene et al.
MOLECULAR MEDICINE (2012)
Pharmacokinetics of xanthohumol and metabolites in rats after oral and intravenous administration
LeeCole Legette et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2012)
Xanthohumol inhibits the neuroendocrine transcription factor achaete-scute complex-like 1, suppresses proliferation, and induces phosphorylated ERK1/2 in medullary thyroid cancer
Mackenzie R. Cook et al.
AMERICAN JOURNAL OF SURGERY (2010)
Notch1 Expression Predicts an Unfavorable Prognosis and Serves as a Therapeutic Target of Patients with Neuroblastoma
Hsiu-Hao Chang et al.
CLINICAL CANCER RESEARCH (2010)
Xanthohumol feeding does not impair organ function and homoeostasis in mice
Christoph Dorn et al.
FOOD AND CHEMICAL TOXICOLOGY (2010)
Targeting Notch pathway induces growth inhibition and differentiation of neuroblastoma cells
Giulia Ferrari-Toninelli et al.
NEURO-ONCOLOGY (2010)
Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis
E. Peuhu et al.
ONCOGENE (2010)
Treatment of PC-3 and DU145 prostate cancer cells by prenylflavonoids from hop (Humulus lupulus L.) induces a caspase-independent form of cell death
L. Delmulle et al.
PHYTOTHERAPY RESEARCH (2008)
Tumor-derived mutations in the TRAIL receptor DR5 inhibit TRAIL signaling through the DR4 receptor by competing for ligand binding
Lianghua Bin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells
Emily C. Colgate et al.
CANCER LETTERS (2007)
Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio
Annick Muehlethaler-Mottet et al.
BMC CANCER (2006)
Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L.) and beer
B Vanhoecke et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol:: NF-κB and Akt as targets
A Albini et al.
FASEB JOURNAL (2005)
Xanthohumol induces apoptosis in cultured 40-16 human colon cancer cells by activation of the death receptor- and mitochondrial pathway
L Pan et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2005)
Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer
P Horak et al.
MOLECULAR CANCER RESEARCH (2005)
Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP
A Mühlethaler-Mottet et al.
ONCOGENE (2004)
Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L
R Di Pietro et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Cell surface death receptor signaling in normal and cancer cells
N Özören et al.
SEMINARS IN CANCER BIOLOGY (2003)
Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer
S Fulda et al.
ONCOGENE (2001)
Bcl-XL protects pancreatic adenocarcinoma cells against CD95-and TRAIL-receptor-mediated apoptosis
S Hinz et al.
ONCOGENE (2000)
Share Paper
